Patient Guide: Safety and Preliminary Efficacy of VIR-5525 and VIR-5525 + Pembrolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • āœ“ Get matched to the right study location for you
  • āœ“ Connect directly with study coordinators at 3 participating sites
  • āœ“ Understand eligibility with our simplified screening tool
  • āœ“ Free service - we're here to help you access clinical research
Trial ID: NCTNCT06960395
Status: 🟢 Enrolling Now
Condition: Solid Tumor Malignancies, EGFR Positive Solid Tumors, EGFR
Phase: PHASE1

Find a Study Location Near You

This study is available at 3 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • • Scottsdale, Arizona
  • • Wollongong, New South Wales
  • • Woolloongabba, Queensland

Loading interactive enrollment tools...

The full interactive experience will load momentarily